Congress

Righ To Try Ad Campaign

Politics

Koch-backed group launches new national ad push to advance ‘right to try’ legislation

By Erin Mershon

Ubl

Pharma

Drug industry’s big trade group breaks its record for lobbying spending in a quarter

By Rebecca Robbins and Erin Mershon

advertisement

Pharmalot

Pharmalittle: Shire rejects latest Takeda offer; Greek parliament ends Novartis bribery probe

By Ed Silverman

advertisement

Lab tests

First Opinion

HHS subverts a congressional plan to make Medicare lab payments fairer

By Julie Khani

CORY BOOKER

Pharmalot

Senator lashes out at drug makers for stock buybacks, but not cutting prices

By Ed Silverman

Prescription Medicine Bottles

Pharmalot

More lawmakers question FDA over probe into Floridians importing medicines

By Ed Silverman

Greg Walden, Ivanka Trump

Politics

House lawmakers hope to bring opioid legislation to vote before Memorial Day

advertisement

Politics

Congress loves shaming CEOs. So why hasn’t pharma been put on the hot seat?

By Erin Mershon

advertisement

Arnolds

Business

A billionaire couple is pumping money into the drug pricing debate. Can they loosen pharma’s grip?

By Rebecca Robbins

Pharmalot

Pharmalittle: Glaxo drops out of bidding for Pfizer consumer unit; Trump policy could hike prices for biosimilars

By Ed Silverman

The Capitol Building

Pharmalot

Most Americans believe pharma has more sway in Washington than the NRA or Wall Street

By Ed Silverman

Pharmalot

Pharmalittle: Glaxo leads race to buy Pfizer consumer unit; U.K. saves $113 million a year on biosimilars

By Ed Silverman

Capitol Hill

Politics

House approves ‘right-to-try’ bill, sending legislation to Senate

By Erin Mershon

Pharmalot

Pharmalittle: Former FDA commissioners don’t like ‘right to try’; former Apotex CEO denies ‘pillow talk’ leaks

By Ed Silverman

Medication samples

First Opinion

Grassley, Leahy: It’s time to empower generic drug makers to bring down prices

By Patrick Leahy and Chuck Grassley

Pharmacy

Pharmalot

Lawmakers want to remove gag clauses that boost drug costs at the pharmacy counter

By Ed Silverman

Lamar Alexander

Politics

Senate signals interest in changes to drug discount program

By Erin Mershon

Kevin McCarthy

Politics

It’s not over: After defeat on ‘right to try,’ GOP vows to renew push

By Erin Mershon

Greg Walden (R-OR)

Politics

‘Right-to-try’ bill rejected by House, in major blow to GOP efforts

By Erin Mershon

Rep. Greg Walden

Politics

‘Right-to-try’ bill would give FDA some oversight, but still frustrates critics

By Erin Mershon

FDA campus

Politics

‘Right-to-try’ law threatens patient safety and rational drug development

By Mark Harrington and Ellen V. Sigal

Politics

Key Republican lawmaker releases new ‘right-to-try’ legislation

By Erin Mershon

U.S. Sen. Claire McCaskill

Pharmalot

McCaskill plans a bill to force pharma to disclose payments to nonprofits and advocacy groups

By Ed Silverman

Capitol Hill

Politics

Republicans working to relax law that would put drug makers on the hook for more costs

By Erin Mershon

Pharmalot

Lawmakers file a bill to block maneuvers like Allergan’s patent deal with Mohawks

By Ed Silverman

"Right to Try" - Ron Johnson

Politics

How the ‘right-to-try’ movement muscled its way into Washington

By Erin Mershon

Senator Claire McCaskill

Pharmalot

McCaskill accuses Teva of ‘stonewalling’ her probe into the opioid crisis

By Ed Silverman

Stethoscope on white background

First Opinion

The steady growth in health care jobs isn’t all positive

By Nisarg A. Patel

Chuck Grassley

Politics

Grassley joins the debate over drug discounts with bill pushing hospitals to disclose payments

By Erin Mershon